Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Health Consultant October 01, 2026 0

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

from NYT > Health https://ift.tt/inTsv9U
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )